Skip to content

Clinical trials

Phase 1/2 Digestive System Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20111
20172
20181
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
DualityBio Inc.1
Erasca, Inc.1
Hoffmann-La Roche1
Kyowa Kirin Co., Ltd.1
Novartis Pharmaceuticals1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Theseus Pharmaceuticals1
Thomas Jefferson University1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Neoplasms9
Gastrointestinal Neoplasms7
Neoplasms6
Digestive System Diseases5
Gastrointestinal Diseases5
Colonic Diseases4
Colorectal Neoplasms4
Intestinal Diseases4
Intestinal Neoplasms4
Neoplasms by Site4

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.